Genky DrugStores Co., Ltd. (9267.T)
JPY 3190.0
(1.11%)
JPY 3190.0
(1.11%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 13.25 Billion | 8.77 Billion | 6.07 Billion | 12.07 Billion | 7.41 Billion | 4.3 Billion |
| Net Income | 6.32 Billion | 6.7 Billion | 6.08 Billion | 6.66 Billion | 4.03 Billion | 3.88 Billion |
| Depreciation & Amortization | 5.56 Billion | 4.95 Billion | 4.59 Billion | 4.05 Billion | 3.76 Billion | 3.32 Billion |
| Deferred income taxes | - | - | - | - | -1.46 Billion | - |
| Stock-based compensation | - | - | - | - | 9.51 Million | - |
| Change in working capital | 320 Million | -835 Million | -1.73 Billion | 2.03 Billion | 1.21 Billion | -2.11 Billion |
| Other non-cash items | 12.54 Billion | -2.05 Billion | -2.86 Billion | -678.98 Million | -143.24 Million | -787.68 Million |
| Investing Cash Flow | -10.63 Billion | -9.73 Billion | -10.58 Billion | -8.82 Billion | -11.22 Billion | -10.94 Billion |
| Investments in PPE | -10.44 Billion | -9.92 Billion | -10.5 Billion | -8.95 Billion | -11 Billion | -10.72 Billion |
| Acquisitions | - | 75 Million | 45 Million | - | - | - |
| Investment purchases | -5 Million | - | -45 Million | - | - | - |
| Sales/Maturities of investments | 2 Million | - | 35.89 Million | 228.84 Million | - | - |
| Other Investing Activities | -186 Million | 117 Million | -117.03 Million | -103.73 Million | -217.09 Million | -223.64 Million |
| Financing Cash Flow | -2.05 Billion | 854 Million | 2.03 Billion | -1.95 Billion | 7.98 Billion | 6.86 Billion |
| Debt repayment | -1.7 Billion | -9.79 Billion | -7.48 Billion | -10.03 Billion | -4.99 Billion | -5.67 Billion |
| Dividends payments | -380 Million | -379 Million | -379.41 Million | -379.51 Million | -379.53 Million | -386.66 Million |
| Common Stock Repurchased | - | 11.03 Billion | -230 Thousand | -671 Thousand | -131 Thousand | -788.24 Million |
| Common Stock Issuance | 27 Million | 3 Million | 13.13 Million | 8.45 Billion | 13.36 Billion | 13.71 Billion |
| Other Financing Activities | -1 Million | -1 Million | 9.88 Billion | -2000.00 | -2000.00 | -2000.00 |
| Accounts receivables | -759 Million | -1.12 Billion | -198 Million | -308 Million | -1.16 Billion | -342 Million |
| Accounts payables | 1.99 Billion | 1.62 Billion | 948.65 Million | 2.35 Billion | 3.47 Billion | 920.91 Million |
| Inventory | -1.6 Billion | -1.57 Billion | -1.52 Billion | -1.1 Billion | -1.53 Billion | -2.76 Billion |
| Other working capital | 686 Million | 242 Million | -960.07 Million | 1.08 Billion | 434.51 Million | 62.95 Million |
| Cash at beginning of period | 5.32 Billion | 5.43 Billion | 7.91 Billion | 6.62 Billion | 2.44 Billion | 2.22 Billion |
| Cash at end of period | 5.89 Billion | 5.32 Billion | 5.43 Billion | 7.91 Billion | 6.62 Billion | 2.44 Billion |
| Capital Expenditure | -10.44 Billion | -9.92 Billion | -10.5 Billion | -8.95 Billion | -11 Billion | -10.72 Billion |
| Effect of forex changes on cash | - | - | 35 Thousand | 17 Thousand | -145 Thousand | -3.61 Million |
| Net cash flow / Change in cash | 567 Million | -109 Million | -2.47 Billion | 1.29 Billion | 4.17 Billion | 216.12 Million |
| Free Cash Flow | 2.81 Billion | -1.15 Billion | -4.43 Billion | 3.12 Billion | -3.59 Billion | -6.42 Billion |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.32 Billion | 1.86 Billion | 1.36 Billion | 1.64 Billion | 1.44 Billion | 6.7 Billion |
| Depreciation & Amortization | 5.56 Billion | - | - | 1.36 Billion | 1.29 Billion | 4.95 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 320 Million | - | - | - | - | -835 Million |
| Other non-cash items | 12.54 Billion | -1.86 Billion | -1.36 Billion | -1.64 Billion | -1.44 Billion | -2.05 Billion |
| Investing Cash Flow | -10.63 Billion | - | - | - | - | -9.73 Billion |
| Investments in PPE | -10.44 Billion | - | - | - | - | -9.92 Billion |
| Acquisitions | - | - | - | - | - | 75 Million |
| Investment purchases | -5 Million | - | - | - | - | - |
| Sales/Maturities of investments | 2 Million | - | - | - | - | - |
| Other Investing Activities | -186 Million | - | - | - | - | 117 Million |
| Financing Cash Flow | -2.05 Billion | - | - | - | - | 854 Million |
| Debt repayment | -1.7 Billion | - | - | - | - | -9.79 Billion |
| Dividends payments | -380 Million | - | - | - | - | -379 Million |
| Common Stock Repurchased | - | - | - | - | - | 11.03 Billion |
| Common Stock Issuance | 27 Million | - | - | - | - | 3 Million |
| Other Financing Activities | -1 Million | - | - | - | - | -1 Million |
| Accounts receivables | -759 Million | - | - | - | - | -1.12 Billion |
| Accounts payables | 1.99 Billion | - | - | - | - | 1.62 Billion |
| Inventory | -1.6 Billion | - | - | - | - | -1.57 Billion |
| Other working capital | 686 Million | - | - | - | - | 242 Million |
| Cash at beginning of period | 5.32 Billion | - | - | 4.41 Billion | 5.32 Billion | 5.43 Billion |
| Cash at end of period | 5.89 Billion | - | - | 4.06 Billion | 4.41 Billion | 5.32 Billion |
| Capital Expenditure | -10.44 Billion | - | - | - | - | -9.92 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 567 Million | - | - | -348 Million | -917 Million | -109 Million |
| Free Cash Flow | 2.81 Billion | - | - | 2.72 Billion | 2.59 Billion | -1.15 Billion |
BPMUF
0N0B
ALNLF
DR
0804
AVB